Xinpei Ci

1.5k citations
23 papers · 691 indexed · h-index 15
Topics
Prostate Cancer Treatment and Research (12 papers)Cancer-related gene regulation (9 papers)Kruppel-like factors research (8 papers)
Journals
Nature CommunicationsSHILAP Revista de lepidopterologíaPLoS ONE
Partner nations
CanadaChinaUnited States

In The Last Decade

Xinpei Ci

21 papers receiving 688 citations

Peers

Xinpei Ci
Comparison fields: 5 of 70
  • Molecular Biology 446
  • Pulmonary and Respiratory Medicine 261
  • Cancer Research 261
  • Oncology 130
  • Genetics 90
Replace Yen‐Nien Liu with:
Yen‐Nien Liu Taiwan
João D. Barros‐Silva Portugal
Dejuan Yang China
Jason Kirk United States
Karthik V. Giridhar United States
Francesco Morra Italy
Tzu‐Ju Chen Taiwan
Monica Mannelqvist Norway
Fumiko Chiwaki Japan
Xinpei Ci relative to Yen‐Nien Liu Taiwan Yen‐Nien Liu's profile →
Citations per field
00.5×1.5×
Yen‐Nien Liu · 1×
Citations per year

Countries citing papers authored by Xinpei Ci

Since Specialization
Citations

This map shows the geographic impact of Xinpei Ci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinpei Ci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinpei Ci more than expected).

Fields of papers citing papers by Xinpei Ci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinpei Ci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinpei Ci. The network helps show where Xinpei Ci may publish in the future.

Co-authorship network of co-authors of Xinpei Ci

This figure shows the co-authorship network connecting the top 25 collaborators of Xinpei Ci. A scholar is included among the top collaborators of Xinpei Ci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinpei Ci. Xinpei Ci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 114
4 0
5 23
6 17
7 17
8 29
9 18
10 55
11 14
12 14
13 15
14 5
15 13
16 95
17 32
18 21
19 43
20 32

About Xinpei Ci

Xinpei Ci is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 23 papers that have together received 691 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (12 papers), Cancer-related gene regulation (9 papers) and Kruppel-like factors research (8 papers). The work is most often cited by research in Cancer Research (261 citations), Pulmonary and Respiratory Medicine (261 citations) and Molecular Biology (446 citations). Xinpei Ci has collaborated with scholars based in Canada, China and United States. Frequent co-authors include Yuzhuo Wang, Dong Lin, Francesco Crea, Stephen Yiu Chuen Choi, Jin‐Tang Dong, Colin C. Collins, Hui Xue, Baotong Zhang, Zhiqian Zhang and Yu Wang. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026